Panacea Biotec Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 4,599.5 million compared to INR 6,612.3 million a year ago. Revenue was INR 5,116.1 million compared to INR 6,722 million a year ago.

Net loss was INR 337.5 million compared to net income of INR 10,783.4 million a year ago. Basic loss per share from continuing operations was INR 5.51 compared to basic earnings per share from continuing operations of INR 176.05 a year ago.